Latest Whitepapers

The COVID-19 pandemic has continued to spread worldwide, with an increasing number of global infections and the continual emergence of new variants. Are the existing vaccines still effective against new variants?

Quality Assurance in In Vitro Transcribed RNA Vaccine Development Using Agilent Automated Electrophoresis Instruments

Download this whitepaper to discover assay development tools that can help you to image various dyes with different excitation and emission wavelengths, achieve a high degree of photostability as well as detect the presence of proteins including SARS-CoV-2's spike protein.

The battle against COVID-19 only begins with a test to identify who is infected and who is not. To accelerate an effective response, we have to move beyond the initial diagnosis to prognosis: Who is most susceptible to developing serious, life-threatening symptoms?

Download this whitepaper to discover how a contract development manufacturing organization was able to establish an AAV production platform and much more.

The efficiency of candidate antibody discovery pipelines is directly connected to the quality of the DNA library being screened. To reduce discovery timelines, researchers need access to tools allowing them to take more shots on goal, as well as line up these shots effectively.

Immunotherapy has the potential to treat a wide variety of conditions, from autoimmune disease to cancer. However, the discovery of potential antibody therapeutics against key receptor proteins remains a major challenge for the traditional immunisation approaches currently available on the market.

Currently, various treatments are available to cancer patients, such as chemotherapy, targeted therapy and immunotherapy. Targeted therapy is a type of precision medicine that targets the proteins that control the growth, division and spread of cancer cells.

Biobanks and biorepositories play a crucial role in medical research by offering robust, readily available and even rare biospecimen samples for clinical, biomedical and research studies.

Since the first cases of COVID-19 were identified in December 2019, the disease has spread across the world, claiming over half a million lives and affecting millions of others.